Skip to main content
Premium Trial:

Request an Annual Quote

BCW Index Closes Slightly Higher

The BCW Index closed up .37 percent for the five-day trading period ended Tuesday. Leading gainers for the week were Qiagen, PerkinElmer, and Molecular Devices, which all rose more than 5 percent for the week. Invitrogen led decliners with a 5.4 percent drop.

In comparison, the Dow Jones Industrial Average fell .1 percent, the Nasdaq climbed 1.1 percent, and the Nasdaq Biotech Index closed up 2.2 percent.

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(Oct. 4, 2005)
Last Price
(Sept. 27, 2005)
% Change
Agilent
A
32.46
33.46
-2.99
Applied Biosystems
ABI
23.62
22.75
3.82
Beckman
BEC
54.59
54
1.09
Bio-Rad
BIO
55.06
54.41
1.19
Bruker
BRKR
4.52
4.44
1.80
Fisher Scientific
FSH
61.5
62
-0.81
GE
GE
32.85
33.64
-2.35
Harvard Bio
HBIO
3.08
2.96
4.05
Invitrogen
IVGN
72.85
76.99
-5.38
Molecular Devices
MDCC
21.33
20.23
5.44
PerkinElmer
PKI
20.65
19.57
5.52
Qiagen
QGEN
13.53
12.8
5.70
Sigma
SIAL
63.66
62.54
1.79
Stratagene
STGN
9.27
8.89
4.27
Thermo
TMO
30.94
30.4
1.78
Waters
WAT
43.3
42.13
2.78
Index Average
33.95
33.83
0.37
The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.